Nutrition 21
This article was originally published in The Tan Sheet
Executive Summary
Third quarter net income increases 44% to $2.3 mil. due, in part, to settlement proceeds from patent infringement litigation, Chromax chromium picolinate maker announces April 26. Revenues for third quarter ended March 31 were $6.4 mil., down 18% from prior-year period, with reduction primarily reflecting price changes instituted in August. Core ingredients sales volume rose 51% in the quarter, while operating expenses decreased 21%, firm says